{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:23:36Z","timestamp":1793467416654,"version":"4.5.0"},"reference-count":66,"publisher":"American Chemical Society (ACS)","issue":"24","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023000","name":"Yenepoya University","doi-asserted-by":"publisher","award":["YU\/Seed Grant\/112-2022"],"award-info":[{"award-number":["YU\/Seed Grant\/112-2022"]}],"id":[{"id":"10.13039\/100023000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2021\/002267"],"award-info":[{"award-number":["CRG\/2021\/002267"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004728","name":"VIT University","doi-asserted-by":"publisher","award":["SG20250014"],"award-info":[{"award-number":["SG20250014"]}],"id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A series of ruthenium(II), iridium(III), and rhenium(I) complexes incorporating a 2-bromopyridine imidazophenanthroline ligand were synthesized and initially poised as photodynamic therapy candidates, supported by TD-DFT and excited-state lifetime data. Interestingly, cytotoxicity studies in triple negative cancer cells (MDA-MB-231) showed only marginal light-induced effects and low phototoxicity index values; the photodynamic therapeutic potential fell short. In contrast, the ruthenium complex [RuL] delivered striking anticancer activity in the dark, marking a clear shift toward chemodynamic therapy. Ruthenium complexes induced robust ROS generation, mitochondrial membrane disruption, and intrinsic apoptosis, all independent of light. Its mitochondrial localization, G0\/G1 arrest, and gene modulation (\u2191TP53, \u2191BAX, and \u2193BCL-2) confirmed a mitochondria-targeted CDT mechanism.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c02400","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T21:51:11Z","timestamp":1765144271000},"page":"26263-26279","source":"Crossref","is-referenced-by-count":4,"title":["Turning the\nSpotlight\nAway from PDT: Chemodynamic\nDominance of 2-(2-Bromopyridin-4-yl)-1\n                    <i>H<\/i>\n                    -imidazo[4,5-\n                    <i>f<\/i>\n                    ][1,10]phenanthroline\nBased Ru(II)\/Ir(III)\/Re(I) Complexes against MDA-MB-231"],"prefix":"10.1021","volume":"68","author":[{"given":"Rishav","family":"Das","sequence":"first","affiliation":[{"name":"Vellore Institute of Technology , , ,","place":["Vellore, Tamilnadu, India, 632014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanooja","family":"Shanavas","sequence":"additional","affiliation":[{"name":"Yenepoya (Deemed to be University) , , University Road, Derlakatte , , ,","place":["Mangalore, Karnataka, India, 575018"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal","family":"Das","sequence":"additional","affiliation":[{"name":"Vellore Institute of Technology , , ,","place":["Vellore, Tamilnadu, India, 632014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kushwaha","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology (BHU) , , , ,","place":["Varanasi, Uttar Pradesh, India, 221005"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinku","family":"Chakrabarty","sequence":"additional","affiliation":[{"name":"Alipurduar University , , , ,","place":["Alipurduar, West Bengal, India, 736122"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4393-4447","authenticated-orcid":true,"given":"Samya","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology (BHU) , , , ,","place":["Varanasi, Uttar Pradesh, India, 221005"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajit","family":"Chaudhury","sequence":"additional","affiliation":[{"name":"Yenepoya (Deemed to be University) , , University Road, Derlakatte , , ,","place":["Mangalore, Karnataka, India, 575018"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shenoy P","sequence":"additional","affiliation":[{"name":"Yenepoya (Deemed to be University) , , University Road, Derlakatte , , ,","place":["Mangalore, Karnataka, India, 575018"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipasha","family":"Bose","sequence":"additional","affiliation":[{"name":"Yenepoya (Deemed to be University) , , University Road, Derlakatte , , ,","place":["Mangalore, Karnataka, India, 575018"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1698-4895","authenticated-orcid":true,"given":"Priyankar","family":"Paira","sequence":"additional","affiliation":[{"name":"Vellore Institute of Technology , , ,","place":["Vellore, Tamilnadu, India, 632014"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"issue":"6","key":"2026072715481356900_cit1","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/his.12727","article-title":"Tracing Differences\nbetween Male and Female Breast Cancer: Both Diseases Own a Different\nBiology","volume":"67","author":"Kornegoor","year":"2015","journal-title":"Histopathology"},{"key":"2026072715481356900_cit2","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/S0305-7372(10)70025-6","article-title":"Treatment\nof Triple Negative Breast Cancer (TNBC): Current Options and Future\nPerspectives","volume":"36","author":"De Laurentiis","year":"2010","journal-title":"Cancer Treat Rev."},{"issue":"1\u20132","key":"2026072715481356900_cit3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2991\/j.jegh.2018.09.003","article-title":"Burden of\nBreast Cancer in the Arab\nWorld: Findings from Global Burden of Disease, 2016","volume":"8","author":"Hashim","year":"2018","journal-title":"J. Epidemiol Glob Health"},{"key":"2026072715481356900_cit4","doi-asserted-by":"publisher","first-page":"1132816","DOI":"10.3389\/fonc.2023.1132816","article-title":"Burden of Breast Cancer and Attributable\nRisk Factors in the North Africa and Middle East Region, 1990\u20132019:\nA Systematic Analysis for the Global Burden of Disease Study 2019","volume":"13","author":"Azadnajafabad","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"2026072715481356900_cit5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13690-022-00918-y","article-title":"Burden of Female\nBreast Cancer in the Middle East and North Africa Region, 1990\u20132019","volume":"80","author":"Safiri","year":"2022","journal-title":"Archives of Public Health"},{"issue":"3","key":"2026072715481356900_cit6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/cancers12030696","article-title":"Factors Associated\nwith Health-Related Quality of Life in Women with Breast Cancer in\nthe Middle East: A Systematic Review","volume":"12","author":"El Haidari","year":"2020","journal-title":"Cancers\n(Basel)"},{"issue":"2","key":"2026072715481356900_cit7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbcan.2009.06.003","article-title":"ERalpha-Negative\nand Triple Negative Breast Cancer: Molecular Features\nand Potential Therapeutic Approaches","volume":"1796","author":"Chen","year":"2009","journal-title":"Biochim.\nBiophys. Acta"},{"issue":"15","key":"2026072715481356900_cit8","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.7150\/jca.23023","article-title":"Subtyping\nOf Triple Negative Breast Carcinoma On The Basis Of RTK Expression","volume":"9","author":"Hessel","year":"2018","journal-title":"J. Cancer"},{"key":"2026072715481356900_cit9","doi-asserted-by":"publisher","DOI":"10.4021\/wjon681e","article-title":"Molecular Mechanism and Targeted\nTherapy Options of Triple-Negative (ER, PgR, HER-2\/Neu) Breast Cancer:\nReview","author":"Kandula","year":"2013","journal-title":"World J. Oncol"},{"issue":"7","key":"2026072715481356900_cit10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s12276-023-01030-z","article-title":"Genomic\nCharacteristics of Triple Negative Apocrine Carcinoma: A Comparison\nto Triple Negative Breast Cancer","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol. Med."},{"issue":"7","key":"2026072715481356900_cit11","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple Negative Breast Cancer Treatment\nOptions and Limitations: Future Outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"2026072715481356900_cit12","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/annonc\/mdv022","article-title":"Genetics of Breast\nCancer: A Topic in Evolution","volume":"26","author":"Shiovitz","year":"2015","journal-title":"Annals of Oncology"},{"issue":"9","key":"2026072715481356900_cit13","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1634\/theoncologist.2016-0067","article-title":"Biology and\nManagement of Patients With Triple-Negative Breast Cancer","volume":"21","author":"Sharma","year":"2016","journal-title":"Oncologist"},{"issue":"11","key":"2026072715481356900_cit14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-Negative\nBreast Cancer: Challenges and Opportunities of a Heterogeneous Disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin Oncol"},{"issue":"1","key":"2026072715481356900_cit15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American\nSociety\nof Clinical Oncology\/College of American Pathologists Guideline Recommendations\nfor Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"2026072715481356900_cit16","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and Progesterone\nReceptor Testing in Breast Cancer: ASCO\/CAP Guideline Update","volume":"38","author":"Allison","year":"2020","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"2026072715481356900_cit17","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","article-title":"Triple-negative Breast\nCancer Therapy: Current and\nFuture Perspectives (Review)","volume":"57","author":"Won","year":"2020","journal-title":"Int. J. Oncol."},{"key":"2026072715481356900_cit18","doi-asserted-by":"publisher","DOI":"10.1200\/PO.21.00201","article-title":"Validity of 1% Hormonal Receptor Positivity Cutoff\nby the ASCO\/College of American Pathologists Guidelines at the Georgia\nCancer Center","volume":"6","author":"Kreidieh","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"2026072715481356900_cit19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41523-021-00308-7","article-title":"Impact of\nEstrogen Receptor Levels on Outcome in Non-Metastatic Triple Negative\nBreast Cancer Patients Treated with Neoadjuvant\/Adjuvant Chemotherapy","volume":"7","author":"Dieci","year":"2021","journal-title":"NPJ. Breast Cancer"},{"issue":"1","key":"2026072715481356900_cit20","doi-asserted-by":"publisher","first-page":"e1664","DOI":"10.1002\/cnr2.1664","article-title":"Characteristics\nof Breast Cancer\nPatients Tested for Germline BRCA1\/2 Mutations by\nNext-generation Sequencing in Ramathibodi Hospital, Mahidol University","volume":"6","author":"Oranratnachai","year":"2023","journal-title":"Cancer Rep"},{"issue":"5","key":"2026072715481356900_cit21","doi-asserted-by":"publisher","first-page":"e841","DOI":"10.1016\/j.clbc.2018.07.023","article-title":"Genetic Markers in\nTriple-Negative Breast Cancer","volume":"18","author":"Sporikova","year":"2018","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"2026072715481356900_cit22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41523-024-00674-y","article-title":"Pathologic Complete\nResponse after Neoadjuvant Systemic Therapy for Breast Cancer in BRCA\nMutation Carriers and Noncarriers","volume":"10","author":"Myers","year":"2024","journal-title":"NPJ. Breast\nCancer"},{"key":"2026072715481356900_cit23","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920975326","article-title":"BRCA1\/2 Pathogenic Variants in Triple-Negative\nversus Luminal-like Breast Cancers: Genotype-Phenotype Correlation\nin a Cohort of 531 Patients","volume":"12","author":"Incorvaia","year":"2020","journal-title":"Ther Adv. Med.\nOncol"},{"issue":"1","key":"2026072715481356900_cit24","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1038\/s41598-025-90150-9","article-title":"Molecular\nProfiling of Breast Cancer Methylation Pattern in Triple Negative\nversus Non- Triple Negative Breast Cancer","volume":"15","author":"Mohanad","year":"2025","journal-title":"Sci.\nRep"},{"issue":"5","key":"2026072715481356900_cit25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/genes13050803","article-title":"Cdh1 Deficiency\nSensitizes TNBC Cells to PARP Inhibitors","volume":"13","author":"Li","year":"2022","journal-title":"Genes\n(Basel)"},{"issue":"8","key":"2026072715481356900_cit26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous Sex Hormones and Breast\nCancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies","volume":"94","author":"The Endogenous Hormones and Breast Cancer Collaborative Group.","year":"2002","journal-title":"CancerSpectrum Knowledge Environment"},{"issue":"2","key":"2026072715481356900_cit27","first-page":"79","article-title":"A Prospective Study\nof Endogenous Hormones and Breast\nCancer","volume":"18","author":"Helzlsouer","year":"1994","journal-title":"Cancer Detect Prev"},{"key":"2026072715481356900_cit28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3389\/fonc.2019.00765","article-title":"The Many\nFaces of Obesity and Its\nInfluence on Breast Cancer Risk","volume":"9","author":"Agurs-Collins","year":"2019","journal-title":"Front Oncol"},{"issue":"1","key":"2026072715481356900_cit29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12905-023-02543-5","article-title":"The Relation between Obesity and\nBreast Cancer Risk\nin Women by Considering Menstruation Status and Geographical Variations:\nA Systematic Review and Meta-Analysis","volume":"23","author":"Dehesh","year":"2023","journal-title":"BMC Womens\nHealth"},{"issue":"11","key":"2026072715481356900_cit30","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.1771","article-title":"Association of Body\nMass Index and Age With Subsequent Breast Cancer Risk in Premenopausal\nWomen","volume":"4","author":"Schoemaker","year":"2018","journal-title":"JAMA Oncol"},{"issue":"3","key":"2026072715481356900_cit31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/bjc.1997.73","article-title":"Body Mass\nIndex and Post-Menopausal Breast Cancer: An Age-Specific Analysis","volume":"75","author":"La Vecchia","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"2","key":"2026072715481356900_cit32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.gendis.2019.09.006","article-title":"Obesity as Potential\nBreast Cancer Risk Factor for\nPostmenopausal Women","volume":"8","author":"Mohanty","year":"2021","journal-title":"Genes Dis"},{"issue":"7","key":"2026072715481356900_cit33","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1590\/1806-9282.20210249","article-title":"Prognostic Factors in Triple-Negative\nBreast Cancer:\nA Retrospective Cohort","volume":"67","author":"Costa","year":"2021","journal-title":"Rev. Assoc Med. Bras"},{"issue":"3","key":"2026072715481356900_cit34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12282-011-0254-9","article-title":"Current Strategy for Triple-Negative\nBreast Cancer: Appropriate Combination of Surgery, Radiation, and\nChemotherapy","volume":"18","author":"Yagata","year":"2011","journal-title":"Breast Cancer"},{"issue":"2","key":"2026072715481356900_cit35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.25122\/jml-2021-0108","article-title":"Triple-Negative Breast Cancer: Current\nTreatment Strategies and Factors of Negative Prognosis","volume":"15","author":"Baranova","year":"2022","journal-title":"J. Med. Life"},{"key":"2026072715481356900_cit36","doi-asserted-by":"publisher","first-page":"770663","DOI":"10.3389\/fphar.2021.770663","article-title":"Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in\nEarly Triple-Negative Breast Cancer: A Narrative Review","volume":"12","author":"Tian","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"2026072715481356900_cit37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00432-024-05738-x","article-title":"Comparison\nof the Efficacy of Taxanes with Carboplatin and Anthracyclines with\nTaxanes in Neoadjuvant Chemotherapy for Stage II-III Triple Negative\nBreast Cancer: A Retrospective Analysis","volume":"150","author":"Wang","year":"2024","journal-title":"J.\nCancer Res. Clin Oncol"},{"issue":"9","key":"2026072715481356900_cit38","doi-asserted-by":"publisher","first-page":"e202404147","DOI":"10.1002\/slct.202404147","article-title":"Exploring\nthe Future\nof Metal-Based Anticancer Agents: A Comprehensive Review of Ruthenium-Based\nComplexes","volume":"10","author":"Bhattacharya","year":"2025","journal-title":"ChemistrySelect"},{"key":"2026072715481356900_cit39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174514","article-title":"Synthesis and Biological\nActivity of 1H-Imidazo[4,5-f][1,10]Phenanthroline as a Potential Antitumor\nAgent with PI3K\/AKT\/MTOR Signaling","volume":"915","author":"Hu","year":"2022","journal-title":"Eur. J.\nPharmacol."},{"issue":"1","key":"2026072715481356900_cit40","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1038\/s41598-024-53228-4","article-title":"Novel Pyridine\nBearing Pentose Moiety-Based Anticancer Agents: Design, Synthesis,\nRadioiodination and Bioassessments","volume":"14","author":"Mehany","year":"2024","journal-title":"Sci. Rep"},{"issue":"6","key":"2026072715481356900_cit41","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2022.103846","article-title":"Novel Pyridine and\nPyrimidine Derivatives as Promising\nAnticancer Agents: A Review","volume":"15","author":"Albratty","year":"2022","journal-title":"Arabian Journal\nof Chemistry"},{"issue":"26","key":"2026072715481356900_cit42","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1039\/D4OB00694A","article-title":"The Discovery of Novel Imidazo[1,2- a ]Pyridine Derivatives as Covalent Anticancer Agents","volume":"22","author":"Song","year":"2024","journal-title":"Org. Biomol Chem."},{"issue":"1","key":"2026072715481356900_cit43","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1038\/s41598-024-53228-4","article-title":"Novel Pyridine\nBearing Pentose Moiety-Based Anticancer Agents: Design, Synthesis,\nRadioiodination and Bioassessments","volume":"14","author":"Mehany","year":"2024","journal-title":"Sci. Rep"},{"issue":"6","key":"2026072715481356900_cit44","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2022.103846","article-title":"Novel Pyridine and\nPyrimidine Derivatives as Promising\nAnticancer Agents: A Review","volume":"15","author":"Albratty","year":"2022","journal-title":"Arabian Journal\nof Chemistry"},{"issue":"3","key":"2026072715481356900_cit45","doi-asserted-by":"publisher","DOI":"10.20883\/medical.e1128","article-title":"Introducing\nBromine to the Molecular\nStructure as a Strategy for Drug Design","volume":"93","author":"Potapskyi","year":"2024","journal-title":"J.\nMed. Sci."},{"issue":"2","key":"2026072715481356900_cit46","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1021\/jm00212a022","article-title":"Lipophilicity and Serotonin Agonist Activity in a Series\nof 4-Substituted Mescaline Analogs","volume":"20","author":"Nichols","year":"1977","journal-title":"J. Med.\nChem."},{"issue":"1","key":"2026072715481356900_cit47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00044-020-02638-w","article-title":"Synthesis and Anticancer Evaluation\nof Amide Derivatives of Imidazo-Pyridines","volume":"30","author":"Rani","year":"2021","journal-title":"Medicinal\nChemistry Research"},{"issue":"42","key":"2026072715481356900_cit48","doi-asserted-by":"publisher","first-page":"15365","DOI":"10.1039\/D3DT01667F","article-title":"GSH Resistant, Luminescent 2-(Pyren-1-Yl)-1 H -Imidazo[4,5- f ][1,10]Phenanthroline-Based\nRu(ii)\/Ir(iii)\/Re(i) Complexes\nfor Phototoxicity in Triple-Negative Breast Cancer Cells","volume":"52","author":"Das","year":"2023","journal-title":"Dalton Transactions"},{"issue":"45","key":"2026072715481356900_cit49","doi-asserted-by":"publisher","first-page":"17263","DOI":"10.1039\/D2DT02237K","article-title":"In Vitro Studies on the Selective Cytotoxic Effect of Luminescent\nRu(ii)- p -Cymene Complexes of Imidazo-Pyridine and\nImidazo Quinoline Ligands","volume":"51","author":"Selvam","year":"2022","journal-title":"Dalton Transactions"},{"issue":"13","key":"2026072715481356900_cit50","doi-asserted-by":"publisher","first-page":"10928","DOI":"10.1021\/acs.jmedchem.4c00406","article-title":"2-Aryl-1 H -Imidazo[4,5- f ][1,10]Phenanthroline-Based\nBinuclear Ru(II)\/Ir(III)\/Re(I) Complexes as Mitochondria Targeting\nCancer Stem Cell Therapeutic Agents","volume":"67","author":"Kar","year":"2024","journal-title":"J. Med.\nChem."},{"issue":"6","key":"2026072715481356900_cit51","doi-asserted-by":"publisher","first-page":"e202401720","DOI":"10.1002\/chem.202401720","article-title":"Photostimulated Anticancer Activity of Mitochondria\nLocalized Rhenium(I)\nTricarbonyl Complexes Bearing 1 H -imidazo[4,5- f ][1,10]Phenanthroline Ligands Against MDA-MB-231 Cancer\nCells","volume":"31","author":"Kar","year":"2025","journal-title":"Chemistry \u2013 A European Journal"},{"issue":"21","key":"2026072715481356900_cit52","doi-asserted-by":"publisher","first-page":"12276","DOI":"10.1021\/ic400835n","article-title":"Next-Generation\nMetal Anticancer Complexes: Multitargeting\nvia Redox Modulation","volume":"52","author":"Romero-Canelo\u0301n","year":"2013","journal-title":"Inorg. Chem."},{"issue":"23","key":"2026072715481356900_cit53","doi-asserted-by":"publisher","first-page":"17689","DOI":"10.1021\/acs.inorgchem.0c02928","article-title":"Mitochondria-Targeting\nClick-Derived Pyridinyltriazolylmethylquinoxaline-Based Y-Shaped Binuclear\nLuminescent Ruthenium(II) and Iridium(III) Complexes as Cancer Theranostic\nAgents","volume":"59","author":"Roy","year":"2020","journal-title":"Inorg. Chem."},{"key":"2026072715481356900_cit54","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.139168","article-title":"Alkali Metals and Ammonium as Cations\nin Dioxidovanadium(V) Complexes with Schiff Base Ligands \u2013\nStructure, Solubility and Stability in Biological Media","volume":"1317","author":"Jurowska","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"48","key":"2026072715481356900_cit55","doi-asserted-by":"publisher","first-page":"25390","DOI":"10.1021\/acs.langmuir.4c02043","article-title":"Sialic Acid-Targeted\nRu(II)\/Ir(III)\/Re(I) Complexes for Ferroptosis Induction in Triple-Negative\nBreast Cancer","volume":"40","author":"Roy","year":"2024","journal-title":"Langmuir"},{"issue":"2","key":"2026072715481356900_cit56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pharmthera.2013.09.006","article-title":"Existing and Potential\nTherapeutic Uses for N-Acetylcysteine:\nThe Need for Conversion to Intracellular Glutathione for Antioxidant\nBenefits","volume":"141","author":"Rushworth","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"3","key":"2026072715481356900_cit57","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/molecules28031447","article-title":"Glutathione-Related\nEnzymes and Proteins: A Review","volume":"28","author":"Vas\u030ckova\u0301","year":"2023","journal-title":"Molecules"},{"key":"2026072715481356900_cit58","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fphar.2014.00196","article-title":"Glutathione:\nNew Roles in Redox Signaling\nfor an Old Antioxidant","volume":"5","author":"Aquilano","year":"2014","journal-title":"Front Pharmacol"},{"issue":"6","key":"2026072715481356900_cit59","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/cssc.201100835","article-title":"Enzymatic versus Microbial Bio-Catalyzed\nElectrodes in Bio-Electrochemical Systems","volume":"5","author":"Lapinsonnie\u0300re","year":"2012","journal-title":"ChemSusChem"},{"issue":"21","key":"2026072715481356900_cit60","doi-asserted-by":"publisher","first-page":"7178","DOI":"10.1039\/C8DT00438B","article-title":"Effect of Sulfonamidoethylenediamine Substituents in\nRu II Arene Anticancer Catalysts on Transfer Hydrogenation of Coenzyme\nNAD + by Formate","volume":"47","author":"Chen","year":"2018","journal-title":"Dalton Transactions"},{"issue":"36","key":"2026072715481356900_cit61","doi-asserted-by":"publisher","first-page":"12865","DOI":"10.1039\/D0DT02069A","article-title":"Hypoxia Efficient and\nGlutathione-Resistant Cytoselective Ruthenium(ii)- p -Cymene-Arylimidazophenanthroline Complexes: Biomolecular\nInteraction and Live Cell Imaging","volume":"49","author":"Mondal","year":"2020","journal-title":"Dalton Transactions"},{"key":"2026072715481356900_cit62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2020.111099","article-title":"Luminescent Anticancer Ru(II)-Arenebipyridine and Phenanthroline\nComplexes: Synthesis, Characterization, DFT Studies, Biological Interactions\nand Cellular Imaging Application","volume":"208","author":"P K","year":"2020","journal-title":"J. Inorg.\nBiochem"},{"issue":"6","key":"2026072715481356900_cit63","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1039\/b107656f","article-title":"Synthesis and DNA Binding Properties of Bioorganometallic\n(\u03b75-Pentamethylcyclopentadienyl)Iridium(Iii) Complexes\nof the Type [(\u03b75-C5Me5)Ir(Aa)(Dppz)]n+ (Dppz = Dipyrido[3,2-a:2\u2032,3\u2032-c]Phenazine,\nn = 1\u20133), with S-Coordinated Amino Acids (Aa) or Peptides","author":"Herebian","year":"2002","journal-title":"J. Chem. Soc., Dalton Trans."},{"issue":"11","key":"2026072715481356900_cit64","doi-asserted-by":"publisher","first-page":"e202401047","DOI":"10.1002\/asia.202401047","article-title":"2,3-bis((4-(Pyridin-2-yl)-1H-1,2,3-Triazol-1-yl)Methyl) Quinoxaline\nBased Cyclometalated Binuclear Ir (III) Complex for Photodynamic Therapy\nin Triple Negative Breast Cancer Cell","volume":"20","author":"U","year":"2025","journal-title":"Chem.\nAsian J."},{"key":"2026072715481356900_cit65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/571913","article-title":"Synthesis Characterization and DNA Interaction Studies\nof a New ZN(II) Complex Containing Different Dinitrogen Aromatic Ligands","volume":"2012","author":"Shahabadi","year":"2012","journal-title":"Bioinorg Chem. Appl."},{"issue":"11","key":"2026072715481356900_cit66","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1016\/j.ejmech.2009.06.009","article-title":"Synthesis,\nCrystal Structure, DNA Interaction and Antioxidant Activities\nof Two Novel Water-Soluble Cu(2+) Complexes Derivated from 2-Oxo-Quinoline-3-Carbaldehyde\nSchiff-Bases","volume":"44","author":"Liu","year":"2009","journal-title":"Eur. J. Med. Chem."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c02400","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/24\/26263\/66290835\/acs.jmedchem.5c02400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/24\/26263\/66290835\/acs.jmedchem.5c02400.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:04:48Z","timestamp":1785182688000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/24\/26263\/5234594\/Turning-the-Spotlight-Away-from-PDT-Chemodynamic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":66,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12,7]]},"published-print":{"date-parts":[[2025,12,25]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02400","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]}}}